- All sections
- C - Chemistrymetallurgy
- C07F - Acyclic, carbocyclic, or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium
- C07F 9/6524 - Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having four or more nitrogen atoms as the only ring hetero atoms
Patent holdings for IPC class C07F 9/6524
Total number of patents in this class: 86
10-year publication summary
|
8
|
6
|
7
|
7
|
2
|
10
|
6
|
7
|
4
|
2
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Cancer Targeted Technology LLC | 28 |
9 |
| Wisconsin Alumni Research Foundation | 3914 |
7 |
| Ventana Medical Systems, Inc. | 1059 |
5 |
| Bristol-myers Squibb Company | 4809 |
3 |
| Astex Therapeutics Limited | 226 |
3 |
| Ustav Organicke Chemie a Biochemie AV CR, V.v.i. | 128 |
3 |
| Mycovia Pharmaceuticals, Inc. | 40 |
3 |
| Centre National de La Recherche Scientifique | 10870 |
2 |
| Sumitomo Chemical Company, Limited | 9044 |
2 |
| Avedro, Inc. | 135 |
2 |
| Blueprint Medicines Corporation | 244 |
2 |
| Bracco Imaging S.p.A. | 307 |
2 |
| European Molecular Biology Laboratory | 322 |
2 |
| Five Eleven Pharma Inc. | 18 |
2 |
| King's College London | 547 |
2 |
| Nagasaki University | 204 |
2 |
| Universite de Bretagne Occidentale | 108 |
2 |
| Auspherix Limited | 8 |
2 |
| The Affiliated Hospital of Southwest Medical University | 8 |
2 |
| Veraxa Biotech GmbH | 16 |
2 |
| Other owners | 27 |